Pfizer tests combined COVID-19 and flu shot
(CNN) - Pfizer has launched its study of a combination COVID-19 and flu vaccine.
On Thursday, Pfizer and its German partner, BioNTech, announced that the first participant has received a dose in Phase 1 of the trial.
The shot contains Pfizer’s updated, bivalent COVID-19 boosters and its flu vaccine.
The bivalent booster targets the original COVID-19 strain and two omicron subvariants.
Other vaccine makers also are studying combination vaccines.
Novavax announced this month that its combination COVID-19 and flu vaccine candidate generated immune responses against coronavirus and influenza strains in an early clinical trial.
Moderna is also developing a combined flu and COVID-19 vaccine and another combination vaccine targeting flu, COVID-19 and RSV.
Copyright 2022 CNN Newsource. All rights reserved.